{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:10:20Z","timestamp":1759533020397,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.arbres.2020.07.006","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T22:15:26Z","timestamp":1597270526000},"page":"823-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens"],"prefix":"10.1016","volume":"56","author":[{"given":"Clara","family":"Carreras-Abad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Espiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"L\u00f3pez-Seguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Mart\u00edn-Begu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mart\u00edn-Nalda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Melendo-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Mendoza-Palomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Soler-Palacin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Simon","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Soriano-Arandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2020.07.006_bib0055","unstructured":"World Health Organization (WHO). Global tuberculosis report 2019. Geneva, Switzerland. 2019. Available from: https:\/\/www.who.int\/tb\/publications\/global_report\/en\/ [accessed 23.04.20]."},{"key":"10.1016\/j.arbres.2020.07.006_bib0060","article-title":"Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs","volume":"6","author":"Huynh","year":"2019","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.arbres.2020.07.006_bib0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(19)31882-3","article-title":"Management of drug-resistant tuberculosis","volume":"394","author":"Lange","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2020.07.006_bib0070","unstructured":"World Health Organization (WHO). Multidrug-resistant tuberculosis in children and adolescents in the WHO European Region Expert opinion. 2019; Available from: http:\/\/www.euro.who.int\/en\/publications\/abstracts\/multidrug-resistant-tuberculosis-in-children-and-adolescents-in-the-who-european-region-2019 [accessed 23.04.20]."},{"key":"10.1016\/j.arbres.2020.07.006_bib0075","article-title":"Update of SEPAR guideline \u201cDiagnosis and Treatment of Drug-Resistant Tuberculosis\u201d [published online ahead of print, 2020 May 20]","author":"Caminero","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2020.07.006_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00055-19","article-title":"Cycloserine population pharmacokinetics and pharmacodynamics in patients with tuberculosis","volume":"63","author":"Alghamdi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arbres.2020.07.006_bib0085","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1212\/WNL.0000000000004247","article-title":"Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: nested case\u2013control study","volume":"89","author":"Sodhi","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arbres.2020.07.006_bib0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3109\/01658107.2010.499524","article-title":"Pseudotumour cerebri syndrome and levofloxacin therapy: a case report","volume":"34","author":"Cellini","year":"2010","journal-title":"Neuro-Ophthalmology"},{"key":"10.1016\/j.arbres.2020.07.006_bib0095","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/INF.0000000000001137","article-title":"Probable levofloxacin-associated secondary intracranial hypertension in a child with multidrug-resistant tuberculosis","volume":"35","author":"Van der Laan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.arbres.2020.07.006_bib0100","article-title":"Levofloxacin and intracranial hypertension in a patient with spondylodiscitis: a case report","volume":"01","author":"Alfieri","year":"2016","journal-title":"Insights Neurosurg"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289620302313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289620302313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:39:22Z","timestamp":1759531162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289620302313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0300289620302313"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2020.07.006","relation":{},"ISSN":["0300-2896"],"issn-type":[{"type":"print","value":"0300-2896"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Events Associated With New Injectable-Free Multidrug-Resistant Tuberculosis Drug Regimens","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2020.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}